Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

Osteoporosis International

Volumn 21, Issue 11, 2010, Pages 1853-1861

  Manghat, P ^a   Fraser, W D ^b   Wierzbicki, A S ^a   Fogelman, I ^c   Goldsmith, D J ^c   Hampson, G ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Bone mineral density; Chronic kidney disease; Fibroblast growth factor 23

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; C REACTIVE PROTEIN; CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; DIABETES MELLITUS; FEMALE; FEMUR NECK; FOREARM; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; C-REACTIVE PROTEIN; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PHOSPHATES; RENAL INSUFFICIENCY, CHRONIC; RENAL OSTEODYSTROPHY; SEVERITY OF ILLNESS INDEX;

EID: 78149412578     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-1142-4     Document Type: Article

References (44)

1. S Moe T Drueke J Cunningham W Goodman K Martin K Olgaard, et al. 2006 Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: Improving global outcomes (KDIGO) Kidney Int 69 11 1945 1953 1:STN:280:DC%2BD283ptl2nug%3D%3D 10.1038/sj.ki.5000414 16641930 (Pubitemid 43924257)
2. KDIGO 2009 Clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int 76 Suppl 113 S22 S49
3. CP Kovesdy K Kalanter-Zadeh 2008 Bone and mineral disorders in pre-dialysis CKD Int Urol Nephrol 40 427 440 10.1007/s11255-008-9346-7 18368510
4. S Liu W Tang J Zhou JR Stubbs Q Luo M Pi LD Quarles 2006 Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D J Am Soc Nephrol 17 1305 1315 1:CAS:528:DC%2BD28XkvVKrs7w%3D 10.1681/ASN.2005111185 16597685 (Pubitemid 43673410)
5. H Saito A Maeda S Ohtomo M Hirata K Kusano S Kato E Ogata H Segawa K Miyamoto N Fukushima 2005 Circulating FGF-23 is regulated by 1alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo J Biol Chem 280 2543 2549 1:CAS:528:DC%2BD2MXmt1yhsQ%3D%3D 10.1074/jbc.M408903200 15531762 (Pubitemid 40189356)
6. M Ito Y Sakai M Furumoto H Segawa S Haito S Yamanaka R Nakamura M Kuwahata KI Miyamoto 2005 Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells Am J Physiol Endocrinol Metab 288 E1101 E1109 1:CAS:528:DC%2BD2MXlsVyls70%3D 10.1152/ajpendo.00502.2004 15671080 (Pubitemid 40726796)
7. X Yu Y Sabbagh SI Davis MB Demay KE White 2005 Genetic dissection of phosphate and vitamin D -mediated regulation of circulating FGF-23 concentrations Bone 36 971 977 1:CAS:528:DC%2BD2MXltFSltL4%3D 10.1016/j.bone.2005.03.002 15869926 (Pubitemid 40797997)
8. JJ Kazama F Sato K Omori H Hama S Yamamoto H Maruyama I Narita F Gejyo T Yamashita S Fukumoto M Fukagawa 2005 Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients Kidney Int 67 1120 1125 1:CAS:528:DC%2BD2MXis1Gqsr8%3D 10.1111/j.1523-1755.2005.00178.x 15698453 (Pubitemid 41623338)
9. H Juppner 2007 Novel regulators of phosphate homeostasis and bone metabolism Ther Apher Dial 11 Suppl 1 S3 S22 1:CAS:528:DC%2BD1cXmsFOisA%3D%3D 10.1111/j.1744-9987.2007.00513.x 17976082 (Pubitemid 350063849)
10. O Gutierrez T Isakova E Rhee A Shah J Holmes G Collerone H Juppner M Wolf 2005 Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease J Am Soc Nephrol Jul 16 7 2205 2215 1:CAS:528:DC%2BD2MXms1egsLs%3D 10.1681/ASN.2005010052 (Pubitemid 41716454)
11. PA Westerberg T Linde B Wikstrom O Ljunggren M Stridsberg TE Larsson 2007 Regulation of fibroblast growth factor-23 in chronic kidney disease Nephrol Dial Transplant 22 11 3202 3207 1:CAS:528:DC%2BD2sXht1KmtrbP 10.1093/ndt/gfm347 17567652 (Pubitemid 350202543)
12. T Shigematsu JJ Kazama T Yamashita S Fukumoto T Hosoya F Gejyo M Fukagawa 2004 Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency Am J Kidney Dis 44 250 256 1:CAS:528:DC%2BD2cXnt1Srsrk%3D 10.1053/j.ajkd.2004. 04.029 15264182 (Pubitemid 38962552)
13. P Urena Torres G Friedlander MC de Vernejoul C Silve D Prie 2008 Bone mass does not correlate with the serum fibroblast growth factor-23 in hemodialysis patients Kidney Int 73 1 102 107 1:CAS:528:DC%2BD2sXhsVaqur7K 10.1038/sj.ki.5002622 17943081 (Pubitemid 350273643)
14. OM Gutierrez M Mannstadt T Isakova JA Rauh-Hain H Tamez A Shah K Smith H Lee R Thadani H Juppner M Wolf 2008 Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 6 584 592 1:CAS:528:DC%2BD1cXpt12qtro%3D 10.1056/NEJMoa0706130 18687639
15. V Menon T Greene X Wang AA Pereira SM Marcovina GJ Beck JW Kusek AJ Collins AS Levey MJ Sarnak 2005 C-reactive protein and albumin as predictors of all cause and cardiovascular mortality in chronic kidney disease Kidney Int 68 766 772 1:CAS:528:DC%2BD2MXpt1WmtLc%3D 10.1111/j.1523-1755.2005.00455.x 16014054 (Pubitemid 43323132)
16. P Stenvinkel A Alvestrand 2002 Inflammation in end-stage renal disease: sources, consequences and therapy Sem Dial 15 329 337 10.1046/j.1525-139X.2002. 00083.x
17. D Sitara S Kim MS Razzaque C Bergwitz T Taguchi C Schuler RG Erben B Lanske 2008 Genetic evidence of serum phosphate-independent functions of fgf-23 on bone PLOS Genetics 4 8 e10000154 10.1371/journal.pgen.1000154
18. H Wang Y Yoshiko R Yamamoto T Minamizaki K Kozai K Tanne JE Aubin N Maeda 2008 Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro J Bone Miner Res 23 939 948 1:CAS:528:DC%2BD1cXnvVGjsL4%3D 10.1359/jbmr.080220 18282132 (Pubitemid 351768812)
19. G Archibald W Bartlett A Brown B Christie A Elliott K Griffith S Pound I Rappaport D Robertson Y Semple P Slane C Whitworth B Williams 2007 UK consensus conference on early chronic kidney disease-6 and 7 february 2007 Nephrol Dial Transplant 22 9 2455 2457 1:STN:280:DC%2BD2srgt1Ckug%3D%3D 10.1093/ndt/gfm268 17557775 (Pubitemid 47365506)
20. F Joseph AM Ahmad M Ul-Haq BH Durham P Whittingham WD Fraser JP Vora 2008 Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis J Bone Miner Res 23 5 721 729 1:CAS:528:DC%2BD1cXmtFyrsbk%3D 10.1359/jbmr.071117 18052753 (Pubitemid 351575026)
21. LD Quarles 2008 Endocrine functions of bone in mineral metabolism J Clin Invest 118 3820 3928 1:CAS:528:DC%2BD1cXhsVKgu73M 10.1172/JCI36479 19033649
22. RC Pereira H Juppner CE Azucena-Serrano O Yadin IB Salusky K Wesseling-Perry 2009 Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease Bone 10.1016/j.bone.2009.08.008 19679205
23. F Daji K Shiizaki S Shimada T Okada K Kunimoto T Sakaguchi I Hatamura T Shigematsu 2009 Regulation of fibroblast growth factor 23 production in bone in uremic rats Nephron 111 61 68 10.1159/000210389
24. H Nishi T Nii-Kono S Nakanishi Y Yamazaki T Yamashita S Fukumoto K Ikeda A Fujimori M Fukagawa 2005 Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism Nephron Clin Pract 101 2 94 99 10.1159/000086347 (Pubitemid 41208897)
25. J Stubbs S Liu LD Quarles 2007 Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease Semin Dial. 20 4 302 308 10.1111/j.1525-139X.2007.00308.x 17635819
26. S Nakanishi JJ Kazama T Nii-Kono K Omori T Yamashita S Fukumoto F Gejyo T Shigematsu M Fukagawa 2005 Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients Kidney Int 67 3 1171 1178 1:CAS:528:DC%2BD2MXis1Gqs78%3D 10.1111/j.1523-1755.2005.00184.x 15698459 (Pubitemid 41623344)
27. Y Imanishi M Inaba K Nakatsuka K Nagasue S Okuno A Yoshihara M Miura A Miyauchi K Kobayashi T Miki T Shoji E Ishimura Y Nishizawa 2004 FGF-23 in patients with end-stage renal disease on hemodialysis Kidney Int. 65 5 1943 1946 1:CAS:528:DC%2BD2cXktl2gur8%3D 10.1111/j.1523-1755.2004.00604.x 15086938 (Pubitemid 38591047)
28. JJ Kazama F Sato K Omori H Hama S Yamamoto H Maruyama I Narita F Geyjo T Yamashita S Fukumoto M Fukagawa 2005 Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients Kidney Int. 67 3 1120 1125 1:CAS:528:DC%2BD2MXis1Gqsr8%3D 10.1111/j.1523-1755.2005.00178.x 15698453 (Pubitemid 41623338)
29. T Kawata Y Imanishi K Kobayashi T Miki A Arnold M Inaba Y Nishizawa 2007 Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism J Am Soc Nephrol 18 2683 2688 1:CAS:528: DC%2BD2sXht1Krs7jJ 10.1681/ASN.2006070783 17855636 (Pubitemid 47531195)
30. V Lavi-Moshayoff J Silver T Naveh-Many 2009 Human PTH gene regulation in vivo using transgenic mice Am J Physiol Renal Physiol 297 F713 F719 1:CAS:528:DC%2BD1MXhtFGrur%2FI 10.1152/ajprenal.00161.2009 19570881
31. T Sato Y Tominaga T Ueki N Goto S Matsuoka A Katayama T Haba K Uchida S Nakanishi JJ Kazama F Gejyo T Yamashita M Fukagawa 2004 Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism Am J Kidney Dis 44 481 487 1:CAS:528:DC%2BD2cXnvVGnur8%3D 15332221 (Pubitemid 39164625)
32. EW Young JM Albert S Satayathum DA Goodkin RL Pisoni T Akiba T Akizawa K Kurokawa J Bommer L Piera FK Port 2005 Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes Prac Patterns Study Kidney Int 67 1179 1187 1:CAS:528:DC%2BD2MXis1Gqs70%3D 10.1111/j.1523-1755.2005.00185.x 15698460 (Pubitemid 41623345)
33. ND Toussaint PG Kerr 2007 Vascular calcification and arterial stiffness in chronic kidney disease; implications and management Nephrology 12 500 509 10.1111/j.1440-1797.2007.00823.x 17803475 (Pubitemid 47366641)
34. KDIGO 2009 Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int 76 Suppl 113 S50 S99
35. G Jean E Bresson JC Terrat T Vanel JM Hurot C Lorriaux B Mayor C Chazot 2009 Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences Nephrol Dial Transplant 24 3 948 955 1:CAS:528:DC%2BD1MXisVSls7o%3D 10.1093/ndt/gfn571 18852190
36. OM Gutierrez JL Januzzi T Isakova K Laliberte K Smith G Collerone A Sarwar U Hoffmann E Coglianese R Christenson TJ Wang C deFillipi M Wolf 2009 Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease Circulation 119 2545 2552 1:CAS:528:DC%2BD1MXmtVKntro%3D 10.1161/CIRCULATIONAHA.108.844506 19414634
37. K Iseki K Kohagura 2007 Anemia as a risk factor for chronic kidney disease Kidney Int 72 S4 S9 10.1038/sj.ki.5002481 (Pubitemid 47609056)
38. F Mallamaci G Tripepi S Cutrupi LS Malatino C Zoccali 2005 Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction and myocardiopathy in patients with ESRD Kidney Int 67 2330 2337 1:CAS:528:DC%2BD2MXlsFyjur8%3D 10.1111/j.1523-1755.2005.00338.x 15882276 (Pubitemid 41623394)
39. F Kojima K Uchida T Ogawa Y Tanaka K Nitta 2008 Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis Int Urol Nephrol 40 1067 1074 1:CAS:528:DC%2BD1cXhtlCjurzK 10.1007/s11255-008-9462-4 18791804
40. H Tanaka T Hamano N Fujii K Tomida I Matsui S Mikami Y Nagasawa T Ito T Moriyama M Horio E Imai Y Isaka H Rakugi 2009 The impact of diabetes mellitus on vitamin D metabolism in predialysis patients Bone 10.1016/j.bone.2009.07.016
41. M Hesse LF Frohlich U Zeitz B Lanske RG Erben 2007 Ablation of vitamin D signalling rescues bone, mineral and glucose homeostasis in FGF-23 deficient mice Matrix Biology 26 75 84 1:CAS:528:DC%2BD2sXhtlOmsbc%3D 10.1016/j.matbio. 2006.10.003 17123805 (Pubitemid 46187039)
42. P Raggi A Bellasi E Ferramosca GA Block P Muntner 2007 Pulse wave velocity is inversely related to vertebral bone density in haemodialysis patients Hypertension 49 1278 1284 1:CAS:528:DC%2BD2sXltl2hs74%3D 10.1161/HYPERTENSIONAHA.107.086942 17420331 (Pubitemid 46809369)
43. ND Toussaint KK Lau BJ Strauss R Kevan KR Polkinghorne 2008 Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease Nephrol Dial Transplant 23 586 593 10.1093/ndt/gfm660 17933842 (Pubitemid 351767633)
44. K Wesseling-Perry RC Pereira H Wang RM Elashoff S Sahney B Gales H Jüppner IB Salusky 2009 Relationship between plasma FGF-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis J Clin Endocrinol Metab 94 2 511 517 1:CAS:528:DC%2BD1MXhvFCqsbo%3D 10.1210/jc.2008-0326 19050056